139 related articles for article (PubMed ID: 21695080)
1. Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion.
Sudarshan S; Shanmugasundaram K; Naylor SL; Lin S; Livi CB; O'Neill CF; Parekh DJ; Yeh IT; Sun LZ; Block K
PLoS One; 2011; 6(6):e21037. PubMed ID: 21695080
[TBL] [Abstract][Full Text] [Related]
2. A Rare Case of Synchronous Fumarate Hydratase-Deficient Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma With Fumarate Hydratase and von Hippel-Lindau Gene Mutations: A Clinicopathologic and Molecular Study.
Wen H; Zheng L; Zhang M; Pan X; Wang D; Qian J; Zhang X; Zhou Q; Chen N
Int J Surg Pathol; 2024 Jun; 32(4):810-816. PubMed ID: 37715637
[TBL] [Abstract][Full Text] [Related]
3. Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.
Valcarcel-Jimenez L; Frezza C
Br J Cancer; 2023 Nov; 129(10):1546-1557. PubMed ID: 37689804
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma.
Drusian L; Nigro EA; Mannella V; Pagliarini R; Pema M; Costa ASH; Benigni F; Larcher A; Chiaravalli M; Gaude E; Montorsi F; Capitanio U; Musco G; Frezza C; Boletta A
Cell Rep; 2018 Jul; 24(5):1093-1104.e6. PubMed ID: 30067967
[TBL] [Abstract][Full Text] [Related]
5. AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Zheng L; Zhang X; Pan X; Huang Z; Zhang M; Xian J; Wei Y; Nie L; Zhang M; Gong J; Chen X; Zhou Q; Zeng H; Chen N
Mod Pathol; 2023 Nov; 36(11):100303. PubMed ID: 37580017
[TBL] [Abstract][Full Text] [Related]
6. FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.
Wilde BR; Chakraborty N; Matulionis N; Hernandez S; Ueno D; Gee ME; Esplin ED; Ouyang K; Nykamp K; Shuch B; Christofk HR
Cancer Discov; 2023 Sep; 13(9):2072-2089. PubMed ID: 37255402
[TBL] [Abstract][Full Text] [Related]
7. Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites.
Bezwada D; Brugarolas J
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259915
[TBL] [Abstract][Full Text] [Related]
8. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.
Patel SA; Hirosue S; Rodrigues P; Vojtasova E; Richardson EK; Ge J; Syafruddin SE; Speed A; Papachristou EK; Baker D; Clarke D; Purvis S; Wesolowski L; Dyas A; Castillon L; Caraffini V; Bihary D; Yong C; Harrison DJ; Stewart GD; Machiela MJ; Purdue MP; Chanock SJ; Warren AY; Samarajiwa SA; Carroll JS; Vanharanta S
Nature; 2022 Jun; 606(7916):999-1006. PubMed ID: 35676472
[TBL] [Abstract][Full Text] [Related]
9. Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer.
Schmid V; Lafleur VN; Lombardi O; Li R; Salama R; Colli L; Choudhry H; Chanock S; Ratcliffe PJ; Mole DR
Sci Rep; 2019 Dec; 9(1):18768. PubMed ID: 31822727
[TBL] [Abstract][Full Text] [Related]
10. Co-opting a Bioorthogonal Reaction for Oncometabolite Detection.
Zengeya TT; Garlick JM; Kulkarni RA; Miley M; Roberts AM; Yang Y; Crooks DR; Sourbier C; Linehan WM; Meier JL
J Am Chem Soc; 2016 Dec; 138(49):15813-15816. PubMed ID: 27960310
[TBL] [Abstract][Full Text] [Related]
11.
Valcarcel-Jimenez L; Rogerson C; Yong C; Schmidt C; Yang M; Cremades-Rodelgo M; Harle V; Offord V; Wong K; Mora A; Speed A; Caraffini V; Tran MGB; Maher ER; Stewart GD; Vanharanta S; Adams DJ; Frezza C
Sci Adv; 2022 Oct; 8(42):eabq8297. PubMed ID: 36269833
[TBL] [Abstract][Full Text] [Related]
12. Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput Screening.
Zhu H; Lee OW; Shah P; Jadhav A; Xu X; Patnaik S; Shen M; Hall MD
SLAS Discov; 2020 Jan; 25(1):43-56. PubMed ID: 31522598
[TBL] [Abstract][Full Text] [Related]
13. Diffuse Carbonic Anhydrase 9 and GATA3 Expression in Fumarate Hydratase Deficient Renal Cell Carcinoma - A Case Report and Immunoprofile Review.
Pacheco RR; Pacheco R; Cooley C; Kaufman R; Akgul M
Int J Surg Pathol; 2024 Feb; 32(1):145-149. PubMed ID: 37050851
[TBL] [Abstract][Full Text] [Related]
14. Aggressive renal cell carcinoma with biphasic papillary and solid clear cell features harboring IDH2 (R172M) mutation.
Zhao M; Xia Y; Wang W
Pathol Res Pract; 2024 Jan; 253():155090. PubMed ID: 38181579
[TBL] [Abstract][Full Text] [Related]
15. Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma.
Fitzsimmons CM; Mandler MD; Lunger JC; Chan D; Maligireddy SS; Schmiechen AC; Gamage ST; Link C; Jenkins LM; Chan K; Andresson T; Crooks DR; Meier JL; Linehan WM; Batista PJ
NAR Cancer; 2024 Mar; 6(1):zcae004. PubMed ID: 38328795
[TBL] [Abstract][Full Text] [Related]
16. Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells.
Gonçalves E; Sciacovelli M; Costa ASH; Tran MGB; Johnson TI; Machado D; Frezza C; Saez-Rodriguez J
Metab Eng; 2018 Jan; 45():149-157. PubMed ID: 29191787
[TBL] [Abstract][Full Text] [Related]
17. Fumarate hydratase as a metabolic regulator of immunity.
Peace CG; O'Carroll SM; O'Neill LAJ
Trends Cell Biol; 2024 Jun; 34(6):442-450. PubMed ID: 37940417
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the detection rate of fumarate peak in
Pan S; Wang J; Liu G; Zhang J; Song Y; Kong W; Zhou Y; Wu G
Clin Radiol; 2024 Jan; 79(1):e80-e88. PubMed ID: 37923625
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations in hereditary and sporadic renal cell carcinoma.
Coffey NJ; Simon MC
Nat Rev Nephrol; 2024 Apr; 20(4):233-250. PubMed ID: 38253811
[TBL] [Abstract][Full Text] [Related]
20. Unmasking the enigma: A case of Fumarate Hydratase-deficient renal cell carcinoma.
Samar MR; Khan W; Rashid YA; Mohammad ATV
Int J Surg Case Rep; 2023 Dec; 113():109054. PubMed ID: 37992668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
